|
Assessment of HIV Infection Risks & Recommendations for HIV Testing |
|
|
4 | (3) |
|
Initial Evaluation of HIV-Infected Adult Patient |
|
|
7 | (2) |
|
Life Cycle of HIV with Sites of Action of Antiretrovirals |
|
|
8 | (1) |
|
Laboratory Tests Commonly Used in the Diagnosis & Management of Infection with HIV-1 and HIV-2 |
|
|
9 | (11) |
|
1993 Revised CDC HIV Classification System & Expanded AIDS Surveillance Definition for Adolescents & Adults |
|
|
20 | (1) |
|
`Performance Status' (Karnofsky Scale)/Who Clinical Staging System |
|
|
21 | (1) |
|
Rapid Oral TMP/SMX Desensitization |
|
|
21 | (2) |
|
Course of HIV Infection/Disease in Adults, Clinical Decision Points |
|
|
22 | (1) |
|
Antiretroviral Therapy (ART) in Treatment-Naive Adults |
|
|
23 | (26) |
|
Antiretroviral Drugs & Adverse Effets |
|
|
38 | (3) |
|
Drug Adverse Effects by Clinical Presentation |
|
|
41 | (3) |
|
Overlapping Toxicites Between Antiretrovirals and Other Drugs Commonly Used in HIV Patient |
|
|
44 | (1) |
|
Anti-HIV Drugs Available Via Expended Access Programs |
|
|
45 | (1) |
|
Monitoring Blood Levels of Antiretroviral Drugs (Therapeutic Drug Monitoring) |
|
|
46 | (1) |
|
Antiretrovirals Appproved or Tentaitively Approved by FDA for International AIDS Relief |
|
|
47 | (2) |
|
Methods for Penicillin Desensitization |
|
|
49 | (1) |
|
HIV/AIDS In Woman/Pregnancy |
|
|
50 | (19) |
|
HIV in the Fetus & Newborn |
|
|
52 | (1) |
|
HIV Infection in Children |
|
|
53 | (1) |
|
Initiation of Antiretroviral Therapy, P. Carinii Prophylaxis & Supportive Therapy |
|
|
54 | (4) |
|
Clinical Cyndromes, Opportunistic Infections, in Infants & Children, which Differ from Adults |
|
|
58 | (2) |
|
Selected Drugs Commonly Used in Children with HIV Infection |
|
|
60 | (8) |
|
Prophylaxis for First Episode of Opportunistic Disease in HIV-Infected Infants & Children |
|
|
68 | (1) |
|
Management of Exposure to HIV-1 & Hepatitis B/C |
|
|
69 | (3) |
|
Primary Prophylactic Antimicrobial Agents Against Opportunistic Pathogens in Adolescents & Adults |
|
|
72 | (2) |
|
Diagnosis & Differential Diagnosis of Clinical Syndromes, Opportunistic Infections & Neoplasms |
|
|
74 | (48) |
|
Immune Reconstitution & Novel Syndromes Associated with ARV RX |
|
|
119 | (3) |
|
Treatment of Specific Infections/Microorganisms in HIV+/AIDS Patient |
|
|
122 | (37) |
|
Activity of Selected Antifungal Drugs Pathogenic Fungi |
|
|
135 | (14) |
|
Activity of Antiviral Agents Against Treatable Pathogenic Viruses |
|
|
149 | (10) |
|
Drugs Used in Treatment &/or Chronic Supppression of AIDS-Relatd Infections: Adverse Effects, Comments, Cost |
|
|
159 | (12) |
|
Selected Pharmacologic Features of Antimicrobial Agents Used in HIV-Associated Infections in Adults |
|
|
171 | (3) |
|
Dosage of Antimicrobial Drugs in Adult Patient with Renal Impairment |
|
|
174 | (8) |
|
No Dosage Adjustment with Renal Insufficiency, by Category |
|
|
181 | (1) |
|
Dosage of Antiretroviral Drugs in Patients with Imparired Hepatic Function |
|
|
181 | (1) |
|
Drug/Drug Interactions: Antiretroviral Drugs & Drugs Used in Treatment of HIV-Associated Infections & Malignancies |
|
|
182 | (8) |
|
Drug-Drug Interactions Between Protease Inhibitors |
|
|
188 | (1) |
|
Drug-Drug Interactions Between Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) & Protease Inhibitors |
|
|
189 | (1) |
|
Antimicrobics in Pregnancy |
|
|
190 | (1) |
|
Spectrum & Treatment of HIV/AIDS-Associated Malignancies |
|
|
191 | (2) |
|
Recommendations for Routine Immunization of HIV+ Children |
|
|
193 | (1) |
|
Immunization of HIV+ Adults (Asymptomatic & Symptomatic) |
|
|
194 | (2) |
|
Measures to be Taken by Physicians in Preparing HIV+ Patients & Individuals Likely to Have `Risks' Behavior for Overseas Travel |
|
|
196 | (1) |
|
Immunization of HIV+ Adults Traveling to Developing Countries |
|
|
197 | (1) |
|
Biologics in Treatment of Hematocytopenias |
|
|
197 | (1) |
|
AIDS Information & Referral Services |
|
|
198 | (1) |
|
List of Generic & Common Trade Names |
|
|
199 | (1) |
| Index |
|
200 | |
